Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide

Biochemical and Biophysical Research Communications

Volumn 357, Issue 2, 2007, Pages 511-516

  Lee, Soo Hyeon ^a   Kim, Sun Hwa ^a   Park, Tae Gwan ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Fusogenic peptide; PEG; Polyelectrolyte complex micelles; siRNA delivery; Vascular endothelial growth factor

Indexed keywords

MACROGOL; PEPTIDE; POLYELECTROLYTE; SMALL INTERFERING RNA; VASCULOTROPIN;

ARTICLE; CANCER INHIBITION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DEGRADATION;

BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; ELECTROLYTES; GENE SILENCING; HUMANS; LIPOSOMES; MALE; MICELLES; POLYETHYLENE GLYCOLS; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34247153120     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.185     Document Type: Article

References (24)

1. Novina C.D., and Sharp P.A. The RNAi revolution. Nature 430 (2004) 161-164
2. Dorsett Y., and Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 3 (2004) 318-329
3. Ryther R.C., Flynt A.S., Phillips III J.A., and Patton J.G. siRNA therapeutics: big potential from small RNAs. Gene Ther. 12 (2005) 5-11
4. Schiffelers R.M., Woodle M.C., and Scaria P. Pharmaceutical prospects for RNA interference. Pharm. Res. 21 (2004) 1-7
5. Raymond M.S., Aslam A., Jun X., Qin Z., Qingquan T., Gert S., Grietje M., Patrick Y.L., Puthuppatampil V.S., and Martin C.W. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32 (2004) 149
6. Thazha P.P., Charles R.A., Prasad D., Timothy A.V., Namir S., Russell J., Brenda R.B., Eric E.S., Rechard H.G., and Balkrishen B. Positional effect of chemical modifications on short interference RNA activity in mammalian cells. J. Med. Chem. 48 (2005) 4247-4253
7. Jeong J.H., Kim S.H., Kim S.W., and Park T.G. Intracellular delivery of poly(ethylene glycol) conjugated antisense oligonucleotide using cationic lipids by formation of self-assembled polyelectrolyte complex micelles. J. Nanosci. Nanotechnol. 6 (2006) 2790-2795
8. Jeong J.H., Kim S.H., and Park T.G. In vivo tumor targeting of ODN-PEG-folic acid/PEI polyelectrolyte complex micelles. J. Biomater. Sci. Polym. Ed. 16 (2005) 1409-1419
9. Jeong J.H., Kim S.H., Kim S.W., and Park T.G. Polyelectrolyte complex micelles composed of c-raf antisense oligodeoxynucleotide-poly(ethylene glycol) conjugate and poly(ethylenimine): effect of systemic administration on tumor growth. Bioconjugate Chem. 16 (2005) 1034-1037
10. Kim S.H., Jeong J.H., Lee S.H., Kim S.W., and Park T.G. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J. Control Release 116 (2006) 123-129
11. Jeong J.H., Kim S.W., and Park T.G. Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide. Bioconjugate Chem. 14 (2003) 473-479
12. Plank C.B., Oberhauser B., Mechtler K., Koch C., and Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269 (1994) 12918-12924
13. Wagner E. Application of membrane-active peptides for non-viral gene delivery. Adv. Drug Deliv. Rev. 38 (1999) 279-289
14. Takuro N., Naoya O., Akitoyo I., Akihiro W., Hisakazu M., Toshiya H., and Haruhiko A. Binding of cationic a-helical peptides to plasmid DNA and their gene transfer abilities into cells. J. Biol. Chem. 272 (1997) 15307-15312
15. Wyman T.B., Nicol F., Zephalti O., Scaria P.V., Plank C., and Szoka F.C. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 36 (1997) 3008-3017
16. Harborth J., Elbashir S.M., Vandenburgh K., Manninga H., Scaringe S.A., Weber K., and Tuschl T. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 13 (2003) 83-105
17. Hassan S.S.M., and Rechnitz G.A. Determination of glutathione and glutathione reductase with a silver sulfide membrane electrode. Anal. Chem. 54 (1982) 1972-1976
18. Jones D.P., Carlson J.L., Samiec P.S., Sternberg P., Mody V.C., Reed R.L., and Brown L.A.S. Glutathione measurement in human plasma: Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin. Chim. Acta. 275 (1998) 175-184
19. Anderson M.E. Glutathione: an overview of biosynthesis and modulation. Chem. Biol. Interact. 112 (1998) 1-14
20. Amarzguioui M., Holen T., Babaie E., and Prydz H. Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res. 31 (2003) 589-595
21. Oishi M., Sasaki S., Nagasaki Y., and Kataoka K. pH-responsive oligodeoxynucleotide (ODN)-poly(ethylene glycol) conjugate through acid-labile beta-thiopropionate linkage: preparation and polyion complex micelle formation. Biomacromolecules 4 (2003) 1426-1432
22. Oishi M., Hayama T., Akiyama Y., Takae S., Harada A., Yamasaki Y., Nagatsugi F., Sasaki S., Nagasaki Y., and Kataoka K. Supramolecular assemblies for the cytoplasmic delivery of antisense oligodeoxynucleotide: polyion complex (PIC) micelles based on poly(ethylene glycol)-SS-oligodeoxynucleotide conjugate. Biomacromolecules 6 (2005) 2449-2454
23. Sonawane N.D., Szoka Jr. F.C., and Verkaman A.S. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 278 (2003) 44826-44831
24. Rittner K., Benavente A., Bompard-Sorlet A., Heitz F., Divita G., Brasseur R., and Jacobs E. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol. Ther. 5 (2002) 104-114